Key facts
- Taikun Fund is a other based in Hangzhou, China with 7 tracked portfolio companies.
- Notable positions include Rob Medical, GCP Clinplus, Kangabio, E-nitiateBio, PathoAI.
About Taikun Fund
Taikun Fund is a direct investment firm based in Hangzhou, China. The firm was established in 2021. The assets of the firm are managed by the executive management team.
Free account
See the whole book
- ·Watchlist + alerts for Taikun Fund's activity
Create free account
No card required
Portfolio, priced
7 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Rob Medical | — | $22.5M | — | |
| GCP Clinplus | — | — | — | |
| Kangabio | — | — | — | |
| E-nitiateBio | — | — | — | |
| PathoAI | — | — | — | |
| Yangli Pharmaceutical | — | — | — | |
| Kind Pharmaceutical | — | — | — |
Frequently asked
- What companies does Taikun Fund invest in?
- Taikun Fund has 7 recorded portfolio companies, including Rob Medical, GCP Clinplus, Kangabio, E-nitiateBio.